Aim Immunotech Inc (AIM) Aim Immunotech Inc (AIM) [[ item.lastPrice ]] [[ item.priceChange ]] ( [[ item.percentChange ]] ) [[ item.tradeTime ]] [NYSE Arca] [[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (Cboe BZX) [[ item.lastPrice ]] [[ item.priceChange ]] ( [[ item.percentChange ]] ) [[ item.tradeTime ]] [NYSE Arca] [[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ( [[ item.percentChangeExt ]] ) [[ item.tradeTimeExt ]] Alerts Watch Help Go To: --Select Page-- Performance Report Interactive Chart Technical Chart Barchart Opinion Trading Strategies Top Trade Alerts Technical Analysis Trader's Cheat Sheet Price History Historical Data News & Headlines Profile SEC Filings Competitors Stock Comparison Earnings Estimates Analyst Ratings Income Statement Cash Flow Balance Sheet

AIM ImmunoTech's Drug Ampligen to Be Tested by Japan's National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19